Investors.pulsebiosciences.com

Investor Relations Pulse Biosciences Inc.

WebPulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the potential to improve the quality of life for patients. The …

Actived: 9 days ago

URL: https://investors.pulsebiosciences.com/

The Top 100 Healthcare Technology Companies of 2021 Pulse …

WebThe Healthcare Technology Report is pleased to announce The Top 100 Healthcare Technology Companies of 2021. This year’s awardees comprise a broad range of …

Category:  Health Go Health

Pulse Biosciences Announces First-in-Human Procedures with its …

WebCompany’s proprietary system used to treat initial five patients in first-in-human feasibility study for patients with atrial fibrillation. HAYWARD, Calif.--(BUSINESS WIRE)--Dec. 20, …

Category:  Health Go Health

Pulse Biosciences Updates on CellFX System Regulatory and …

WebHAYWARD, Calif.--(BUSINESS WIRE)--Jan. 12, 2021-- Pulse Biosciences, Inc. (Nasdaq: PLSE) (“Pulse Biosciences” or the “Company”), a novel bioelectric medicine company …

Category:  Medicine Go Health

Pulse Biosciences’ First Study in a Surgical Application of …

WebFirst prospective clinical feasibility study suggests nsPFA may be a safe and effective method for treating benign thyroid tumors or nodules. HAYWARD, Calif.- …

Category:  Health Go Health

Pulse Biosciences Announces Start of Controlled Launch of the …

WebAs the first-of-its-kind multi-application platform powered by NPS technology delivering nano-second pulses of electrical energy to non-thermally clear cells while protecting …

Category:  Health Go Health

Pulse Biosciences Announces Strategic Change of Focus in …

WebStrategic focus shifting to advance core NPS™ technology in cardiac and oncology sectors, activate additional executive leadership and reduce dermatologic footprint.

Category:  Health Go Health

Pulse Biosciences Announces FDA Clearance for the CellFX® …

Web- CellFX System delivers Nano-Pulse Stimulation Technology in dermatologic procedures - U.S. controlled launch to commence HAYWARD, Calif.--(BUSINESS WIRE)--Feb. 3, …

Category:  Health Go Health

Pulse Biosciences, Inc. Appoints Dr. Gan Dunnington as Chief …

WebThe Investor Relations website contains information about Pulse Biosciences Inc.'s business for stockholders, potential investors, and financial analysts.

Category:  Health Go Health

Pulse Biosciences Announces Health Canada Approval for CellFX® …

WebHAYWARD, Calif. -- (BUSINESS WIRE)--Jun. 9, 2021-- Pulse Biosciences, Inc. (Nasdaq: PLSE) (“Pulse Biosciences” or the “Company”), a novel bioelectric medicine company …

Category:  Medicine Go Health

Pulse Biosciences to Present at the 35th Annual Piper Sandler

WebHAYWARD, Calif.--(BUSINESS WIRE)--Nov. 15, 2023-- Pulse Biosciences, Inc. (Nasdaq: PLSE), a company primarily focused on leveraging its novel and …

Category:  Health Go Health

Pulse Biosciences Reports Second Quarter 2021 Financial Results

WebWe look forward to a broader commercial launch late in the year and toward delivering the benefits of NPS technology to more patients and clinicians.”. Second Quarter 2021 …

Category:  Health Go Health

Pulse Biosciences to Present at the Stifel 2021 Virtual Healthcare

WebHAYWARD, Calif.--(BUSINESS WIRE)--Nov. 4, 2021-- Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company introducing the CellFX® …

Category:  Medicine Go Health

Pulse Biosciences Announces Collaboration with CardioNXT for …

WebSeamless integration of Pulse Biosciences’ nsPFA cardiac circumferential catheter and CardioNXT’s 3D iMap navigation and mapping system. (1) nsPFA cardiac circumferential …

Category:  Health Go Health

Pulse Biosciences Reports Fourth Quarter & Full Year 2022 …

WebCash used in the fourth quarter of 2022 totaled $8.0 million compared to $13.4 million used in the same period in the prior year and $10.6 million used in the third …

Category:  Health Go Health

Pulse Biosciences Appoints Laureen DeBuono to Its Board of …

WebHAYWARD, Calif.--(BUSINESS WIRE)--Oct. 5, 2021-- Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company commercializing the CellFX® System …

Category:  Medicine Go Health

Pulse Biosciences Reports Second Quarter 2022 Financial Results

WebSecond Quarter 2022 Results. Revenue for the three months ended June 30, 2022 was $265 thousand, including System revenue of $209 thousand and Cycle Units …

Category:  Health Go Health

Pulse Biosciences Announces Appointment of Mitchell E. Levinson …

WebHAYWARD, Calif.--(BUSINESS WIRE)--Aug. 19, 2021-- Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company commercializing the CellFX ® System …

Category:  Medicine Go Health

Pulse Biosciences’ Nanosecond Pulsed Field Ablation (nsPFA™) …

WebHAYWARD, Calif.--(BUSINESS WIRE)--May 18, 2023-- Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond …

Category:  Health Go Health

Pulse Biosciences Announces Plans to Initiate a Rights Offering

WebHAYWARD, Calif.--(BUSINESS WIRE)--Mar. 28, 2024-- Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed …

Category:  Health Go Health